We are live on ! Find out more
EUDAW icon

EUDA Health Holdings Warrant

9 hedge funds and large institutions have $404K invested in EUDA Health Holdings Warrant in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

13% more funds holding

Funds holding: 89 (+1)

68% less capital invested

Capital invested by funds: $1.25M → $404K (-$844K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
Reduced
2
Closed
6
Calls
Puts
Net Calls
Net Calls Change

EUDAW Hedge Fund Activity: Q1 2022 in Review

9 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in EUDA Health Holdings Warrant (EUDAW) for Q1 2022, worth a combined $404K — down 68% from $1.25M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new EUDAW positions and 6 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was AQR Arbitrage, opening a new position worth an estimated $92.4K. The largest seller was Mangrove Partners, exiting entirely with an estimated $656K sold.

  • 9 institutional investors held EUDA Health Holdings Warrant (EUDAW) as of Q1 2022, up from 8 in Q4 2021.
  • Funds reported $404K of EUDA Health Holdings Warrant stock for Q1 2022, down 68% quarter-over-quarter.
  • 7 funds opened new EUDA Health Holdings Warrant positions in Q1 2022 and 6 closed out, a net change of +1 holder.
  • The largest EUDA Health Holdings Warrant buyer in Q1 2022 was AQR Arbitrage, an estimated $92.4K added.
  • The largest EUDA Health Holdings Warrant seller in Q1 2022 was Mangrove Partners, an estimated $656K sold.

Based on aggregated 13F filings for Q1 2022.